Conversion of the laboratory synthetic route of the n-aryl-2-benzothiazolamine R116010 to a manufacturing method

Organic Process Research and Development

Volumn 5, Issue 5, 2001, Pages 467-471

  Aelterman, Wim ^a   Lang, Yolande ^a   Willemsens, Bert ^a   Vervest, Ivan ^a   Leurs, Stef ^a   De Knaep, Fons ^a  

^a Janssen Pharmaceutica   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035537541     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op0100201     Document Type: Article

References (24)

1. Miller, W. Cancer 1998, 83(8), 1471-1482.
2. Njar, V.; Nnane, I.; Brodie, A. Abstr. Pap.-Am. Chem. Soc. 1999, 218, MEDI-166.
3. Venet, M.; Mabire, D.; Lacrampre, J.; Sanz, G. (Janssen Pharmaceutica N.V.). Eur. Pat. Appl. 201781, 1996; Chem. Abstr. 1997, 128, 102083.
4. Venet, M.; Mabire, D.; Lacrampre, J.; Sanz, G. (Janssen Pharmaceutica N.V.). Eur. Pat. Appl. 201781, 1996; Chem. Abstr. 1997, 128, 102083.
5. De Porre, P.: Bruynseels, J.; Wouters, W. (Janssen Pharmaceutica N.V.). Eur. Pat. Appl. 204019, 1997; Chem. Abstr. 1999, 131, 78431.
6. De Porre, P.: Bruynseels, J.; Wouters, W. (Janssen Pharmaceutica N.V.). Eur. Pat. Appl. 204019, 1997; Chem. Abstr. 1999, 131, 78431.
7. Wouters, W.; Van Dun, J.; Dillen, A.; Coene, M.: Cools, W.; De Coster, R. Cancer Res. 1992, 52, 2(10), 2841-2846.
8. Freyne, E.; Raeymaekers, A.; Venet, M.; Sanz, G.; Wouters, W.; De Coster. R.; Van Wauwe, J. Bioorg. Med. Chem. Lett. 1998, 8(3), 267-272.
9. Bryson, H.; Wagstaff, A. Drugs Aging 1996, 9(6), 478-484.
10. Anon, N. Drugs R&D 1999, 2(6), 427-430.
11. Van Heusden, J.; Wouters, W.; Ramaekers, F.; Krekels, M.; Dillen, L.; Borgers, M.; Smets, G. Br. J. Cancer 1998, 77(8), 1229-1235.
12. Goss, P.; Oza, A.; Goel, R.; Nabholtz, J.; De Coster, R.; Bruynseels, J.; Reid, Caroline; Wadden, N. Crump; M.; Tye, L. Breast Cancer Res. Treat. 2000, 59(1), 55 -68.
13. Griffin, T.; Woods, T.; Klayman, D. Adv. Heterocycl. Chem. 1975, 18, 99-106.
14. Freeman, H.; Butler, J.; Freeman, L. J. Org. Chem. 1978, 43, 4975-4978.
15. Hartwig, J. Angew. Chem., Int. Ed. Engl. 1997, 37, 22047-2067.
16. Wolfe, J.; Buchwald, S. Tetrahedron Lett. 1997, 38, 6359-6362.
17. Reider, P.; Davis, P.; Hughes, D.; Grabowski, E. J. Org. Chem. 1987, 52, 955-957.
18. Alabaster, R.; Gibson, A.; Johnson, S.; Edwards, J. Cottrell, I. Tetrahedron Asymmetry 1997, 8, 447-450.
19. Shieh, W.-C.; Carlson, J.; Zaunius, G.; J. Org. Chem. 1997, 62, 8271-8272.
20. Chaplin, D.; Johnson, N.; Paul, J.; Potter, G. Tetrahedron Lett. 1998, 39, 6777-6780.
21. Koga, K.; Yamada, S. Chem. Pharm. Bull. 1972, 20(3), 539-542.
22. Dieter, R.; Deo, N.; Lagu, B.; Dieter, J. J. Org. Chem. 1992, 57, 1663-1671.
23. Van der Zeijden, A. Tetrahedron Asymmetry 1995, 6(4), 913-918.
24. Totleben, M.; Freeman, J.; Szmuszkovicz, J. J. Org. Chem. 1997, 62, 7319-7323.